查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1948213

2026年全球小型动物影像（体内）市场报告

Small Animal Imaging (In-Vivo) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，小动物影像（体内影像）市场发展迅速，预计将从2025年的31.5亿美元成长到2026年的35.4亿美元，复合年增长率达12.4%。过去几年的成长可归因于多种因素，例如临床前研究活动的增加、药物研发投资的增加、学术研究经费的增加、动物模型在疾病研究中的广泛应用以及先进成像技术的普及。

预计未来几年，小型动物影像（体内影像）市场规模将快速成长，到2030年将达到55.3亿美元，复合年增长率（CAGR）为11.8%。预测期内的增长可归因于对精准医疗研究工具需求的不断增长、转化研究投资的增加、肿瘤学和神经病学研究的拓展、人工智能辅助诊断技术的日益普及以及对实时生物成像的日益关注。预测期内的关键趋势包括：多模态成像系统的广泛应用、非侵入性生物成像技术的日益普及、基于人工智慧的图像分析的日益整合、纵向疾病监测研究的扩展以及对高分辨率成像能力的日益重视。

预计未来几年，不断增长的医疗保健支出将推动小动物体内成像市场的扩张。医疗保健支出是指医疗保健服务的总支出，包括公共和私人支出，以占国内生产总值) 的百分比表示。医疗保健支出的成长，加上人们健康管理意识的提高，正在推动自我管理以及先进诊断技术的应用，例如将正子断层扫描 (PET) 系统应用于小动物影像。体内小动物影像能够对生物过程进行非侵入性、即时视觉化，透过加速药物研发、加深对疾病的理解以及支持更有效治疗方法的开发，为医疗保健生态系统做出贡献。例如，根据英国国家统计局2024年5月发布的报告，2023年英国医疗保健支出名义上将增加5.6%，而2022年长期健康和社会照护支出实际将增加2.8%。因此，医疗保健支出的成长正在促进小型动物成像（体内成像）市场的成长。

为了满足肿瘤学和神经科学等领域对高精度、定量和高通量临床前研究日益增长的需求，小型动物成像（体内）领域的主要企业越来越重视先进的成像软体解决方案，包括即时动力学分析功能。这些软体解决方案超越了传统的静态单时间点成像，能够连续采集并自动评估动态生物发光讯号随时间的变化，从而产生更全面的动力学曲线，提高可重复性，并增强峰值讯号检测的准确性。例如，总部位于美国的临床前成像技术供应商Spectral Instruments Imaging于2024年4月发布了其最新的体内影像软体Aura 4.5。 Aura 4.5具有“动力学模式”，可自动即时捕捉生物发光讯号的整个时间进程（包括上升期、稳态期和衰减期）。该平台能够自动识别并报告讯号强度峰值，使研究人员能够获得更高的灵敏度和生物学准确性。此外，此次更新简化了资料收集流程，并最大限度地减少了人工操作。这提高了对时间需求较高的研究（例如药物动力学分析、基因表现研究和感染模型）的操作效率。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球小动物影像（体内）市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 身临其境型技术（AR/VR/XR）与数位体验
  • 主要趋势
    • 多模态成像系统的应用日益普及
    • 非侵入性成像技术的应用日益广泛
    • 人工智慧图像分析整合的进展
    • 扩大纵向疾病监测研究
    • 越来越重视高解析度成像能力

第五章 终端用户产业市场分析

  • 製药公司
  • 生技公司
  • 学术研究机构
  • CRO（受託研究机构）
  • 兽医研究中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球小动物影像（体内）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球小动物影像（体内）市场规模、对比及成长率分析
  • 全球小动物影像（体内）市场表现：规模与成长，2020-2025年
  • 全球小动物影像（体内）市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按组件
  • 微型磁振造影、光学成像、核子医学成像及其他组件
  • 透过使用
  • 监测治疗效果、生物分布、确定药物或标靶结合、癌细胞检测、生物标记、纵向研究、表观遗传学
  • 最终用户
  • 兽医诊所、动物医院、动物实验室和研究中心
  • 按类型细分：微型磁振造影
  • 高场微型磁振造影系统、低场微型磁振造影系统、磁振造影造影剂
  • 按类型细分：光学成像
  • 萤光成像系统、生物发光成像系统、光同调断层扫瞄系统
  • 按类型细分：核子医学影像
  • 正子断层扫描（PET）扫描仪、单光子发射电脑断层扫描（SPECT）系统、放射性追踪剂
  • 按类型细分：其他元件
  • X光影像系统、CT影像系统、超音波影像系统

第十章 区域与国家分析

  • 全球小动物影像（体内）市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球小动物影像（体内）市场：按国家/地区、绩效和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 小动物影像（体内）市场：竞争格局与市场份额，2024 年
  • 小动物影像（体内）市场：公司估值矩阵
  • 小动物影像（体内）市场：公司简介
    • Bruker Corporation
    • PerkinElmer Inc.
    • Mediso Ltd.
    • Aspect Imaging Ltd.
    • Spectral Instruments Imaging LLC

第37章：其他领先和创新企业

  • Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs BV, Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal SA, Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年小型动物影像（体内）市场：提供新机会的国家
  • 2030年小型动物影像（体内）市场：充满新机会的细分市场
  • 2030年小型动物影像（体内）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MSAII01_G26Q1

Small animal imaging (in vivo) pertains to advanced imaging techniques designed for monitoring cellular activity, pharmacological effects, and disease progression in live animals. It enables the observation, definition, and quantification of normal and pathologic processes in living animal organs and tissues in a non-invasive manner.

Key components of small animal imaging (in vivo) include micro-MRI, optical imaging, nuclear imaging, and other elements. Micro-MRI, a non-invasive technique, produces detailed three-dimensional (3D) images of tissues without exposing the subject to harmful radiation. This approach finds various applications, such as monitoring treatment response, assessing biodistribution, determining drug/target engagement, detecting cancer cells, exploring biomarkers, conducting longitudinal studies, and investigating epigenetics. These applications are employed in veterinary clinics, veterinary hospitals, as well as veterinary institutes and research centers.

Tariffs are influencing the small animal imaging (in-vivo) market by increasing costs of imported imaging detectors, scanners, contrast agents, electronic components, and precision optics. Research institutions and pharmaceutical laboratories in North America and Europe are most affected due to reliance on advanced imported imaging systems, while Asia-Pacific faces cost pressures on system procurement. These tariffs are increasing capital investment requirements and delaying equipment upgrades. At the same time, they are supporting regional manufacturing partnerships, localized system assembly, and domestic innovation in preclinical imaging technologies.

The small animal imaging (in-vivo) market research report is one of a series of new reports from The Business Research Company that provides small animal imaging (in-vivo) market statistics, including small animal imaging (in-vivo) industry global market size, regional shares, competitors with a small animal imaging (in-vivo) market share, detailed small animal imaging (in-vivo) market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging (in-vivo) industry. This small animal imaging (in-vivo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $3.15 billion in 2025 to $3.54 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growth in preclinical research activities, increasing drug discovery investments, expansion of academic research funding, rising use of animal models in disease studies, availability of advanced imaging modalities.

The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $5.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine research tools, rising investments in translational research, expansion of oncology and neurological studies, growing adoption of ai-assisted diagnostics, increasing focus on real-time biological imaging. Major trends in the forecast period include increasing adoption of multimodal imaging systems, rising use of non-invasive in vivo imaging techniques, growing integration of ai-based image analysis, expansion of longitudinal disease monitoring studies, enhanced focus on high-resolution imaging capabilities.

Increasing healthcare sector spending is anticipated to support the expansion of the small animal imaging (in vivo) market in the coming years. Healthcare expenditure represents the total spending on health services, including both public and private outlays, expressed as a share of gross domestic product. Higher healthcare spending, along with growing awareness of health management, is promoting the adoption of self-care and advanced diagnostic approaches, where positron emission tomography systems are applied in methods such as small animal imaging. In vivo small animal imaging benefits the healthcare ecosystem by enabling noninvasive, real-time visualization of biological processes, accelerating drug discovery timelines, enhancing disease understanding, and supporting the development of more effective therapeutic solutions. For example, in May 2024, a report released by the Office for National Statistics, a United Kingdom-based government statistical authority, indicated that healthcare expenditure in the United Kingdom rose by 5.6% in nominal terms in 2023, while long-term health and social care spending increased by 2.8% in real terms in 2022. As a result, rising healthcare expenditure is contributing to the growth of the small animal imaging (in vivo) market.

Leading companies operating in the small animal imaging (in vivo) space are increasingly emphasizing advanced imaging software solutions, including real-time kinetic analysis capabilities, to address the growing demand for highly accurate, quantitative, and high-throughput preclinical research in areas such as oncology and neuroscience. These software solutions enable continuous acquisition and automated evaluation of dynamic bioluminescent signals over time, moving beyond conventional static single-timepoint imaging and generating more comprehensive kinetic profiles, improved reproducibility, and enhanced detection of peak signal phases. For instance, in April 2024, Spectral Instruments Imaging, a United States-based provider of preclinical imaging technologies, introduced Aura 4.5, the newest release of its in vivo imaging software. Aura 4.5 features a Kinetics mode that supports automated, real-time capture of bioluminescent signals across their entire temporal progression, including rise, plateau, and decay phases. The platform automatically determines and reports peak signal intensity, enabling researchers to achieve greater sensitivity and biological precision. In addition, the update simplifies data collection and minimizes manual handling, improving operational efficiency for longitudinal and time-critical studies such as pharmacokinetic analyses, gene expression research, and infection models.

In February 2024, Bruker Corporation, a US-based biotechnology research company, acquired Spectral Instruments Imaging for an undisclosed sum. This acquisition is intended to bolster Bruker Corporation's imaging technology capabilities, particularly in advanced imaging systems for life sciences and materials research. The integration of Spectral Instruments Imaging's expertise in specialized imaging solutions will enhance Bruker's offerings in this area. Spectral Instruments Imaging is a US-based company known for its advanced imaging solutions.

Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small animal imaging (in-vivo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The small animal imaging (in-vivo) market includes revenues earned by PET, X-ray CT, MRI, and SPECT scanners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Animal Imaging (In-Vivo) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses small animal imaging (in-vivo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small animal imaging (in-vivo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small animal imaging (in-vivo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Micro-MRI; Optical Imaging; Nuclear Imaging; Other Components
  • 2) By Application: Monitoring Treatment Response; Bio Distribution, Determining Drug or Target Engagement; Cancer Cell Detection; Biomarkers; Longitudinal Studies; Epigenetics
  • 3) By End User: Veterinary Clinics; Veterinary Hospitals; Veterinary Institutes and Research Centers
  • Subsegments:
  • 1) By Micro-MRI: High-Field Micro-MRI Systems; Low-Field Micro-MRI Systems; MRI Contrast Agents
  • 2) By Optical Imaging: In Vivo Fluorescence Imaging Systems; Bioluminescence Imaging Systems; Optical Coherence Tomography Systems
  • 3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners; Single Photon Emission Computed Tomography (SPECT) Systems; Radioactive Tracers
  • 4) By Other Components: X-Ray Imaging Systems; CT Imaging Systems; Ultrasound Imaging Systems
  • Companies Mentioned: Bruker Corporation; PerkinElmer Inc.; Mediso Ltd.; Aspect Imaging Ltd.; Spectral Instruments Imaging LLC; Bioscan Inc.; Gamma Medica-Ideas Inc.; LI-COR Biosciences; Scanco Medical AG; TriFoil Imaging Inc.; MR Solutions Ltd.; MILabs B.V.; Trifoil Imaging Inc.; VisualSonics Inc.; Fujifilm VisualSonics Inc.; Sedecal S.A.; Kubtec Medical Imaging; Carestream Health Inc.; Thermo Fisher Scientific Inc.; Rigaku Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Small Animal Imaging (In-Vivo) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Small Animal Imaging (In-Vivo) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Small Animal Imaging (In-Vivo) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Small Animal Imaging (In-Vivo) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Multimodal Imaging Systems
    • 4.2.2 Rising Use Of Non-Invasive In Vivo Imaging Techniques
    • 4.2.3 Growing Integration Of Ai-Based Image Analysis
    • 4.2.4 Expansion Of Longitudinal Disease Monitoring Studies
    • 4.2.5 Enhanced Focus On High-Resolution Imaging Capabilities

5. Small Animal Imaging (In-Vivo) Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Academic Research Institutes
  • 5.4 Contract Research Organizations
  • 5.5 Veterinary Research Centers

6. Small Animal Imaging (In-Vivo) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Small Animal Imaging (In-Vivo) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Small Animal Imaging (In-Vivo) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Small Animal Imaging (In-Vivo) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Small Animal Imaging (In-Vivo) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Small Animal Imaging (In-Vivo) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Small Animal Imaging (In-Vivo) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Small Animal Imaging (In-Vivo) Market Segmentation

  • 9.1. Global Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
  • 9.2. Global Small Animal Imaging (In-Vivo) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
  • 9.3. Global Small Animal Imaging (In-Vivo) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
  • 9.4. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Micro-MRI, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents
  • 9.5. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Optical Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
  • 9.6. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Nuclear Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers
  • 9.7. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Other Components, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

10. Small Animal Imaging (In-Vivo) Market Regional And Country Analysis

  • 10.1. Global Small Animal Imaging (In-Vivo) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Small Animal Imaging (In-Vivo) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Small Animal Imaging (In-Vivo) Market

  • 11.1. Asia-Pacific Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Small Animal Imaging (In-Vivo) Market

  • 12.1. China Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Small Animal Imaging (In-Vivo) Market

  • 13.1. India Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Small Animal Imaging (In-Vivo) Market

  • 14.1. Japan Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Small Animal Imaging (In-Vivo) Market

  • 15.1. Australia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Small Animal Imaging (In-Vivo) Market

  • 16.1. Indonesia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Small Animal Imaging (In-Vivo) Market

  • 17.1. South Korea Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Small Animal Imaging (In-Vivo) Market

  • 18.1. Taiwan Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Small Animal Imaging (In-Vivo) Market

  • 19.1. South East Asia Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Small Animal Imaging (In-Vivo) Market

  • 20.1. Western Europe Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Small Animal Imaging (In-Vivo) Market

  • 21.1. UK Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Small Animal Imaging (In-Vivo) Market

  • 22.1. Germany Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Small Animal Imaging (In-Vivo) Market

  • 23.1. France Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Small Animal Imaging (In-Vivo) Market

  • 24.1. Italy Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Small Animal Imaging (In-Vivo) Market

  • 25.1. Spain Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Small Animal Imaging (In-Vivo) Market

  • 26.1. Eastern Europe Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Small Animal Imaging (In-Vivo) Market

  • 27.1. Russia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Small Animal Imaging (In-Vivo) Market

  • 28.1. North America Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Small Animal Imaging (In-Vivo) Market

  • 29.1. USA Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Small Animal Imaging (In-Vivo) Market

  • 30.1. Canada Small Animal Imaging (In-Vivo) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Small Animal Imaging (In-Vivo) Market

  • 31.1. South America Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Small Animal Imaging (In-Vivo) Market

  • 32.1. Brazil Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Small Animal Imaging (In-Vivo) Market

  • 33.1. Middle East Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Small Animal Imaging (In-Vivo) Market

  • 34.1. Africa Small Animal Imaging (In-Vivo) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Small Animal Imaging (In-Vivo) Market Regulatory and Investment Landscape

36. Small Animal Imaging (In-Vivo) Market Competitive Landscape And Company Profiles

  • 36.1. Small Animal Imaging (In-Vivo) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Small Animal Imaging (In-Vivo) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Small Animal Imaging (In-Vivo) Market Company Profiles
    • 36.3.1. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Mediso Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Aspect Imaging Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Spectral Instruments Imaging LLC Overview, Products and Services, Strategy and Financial Analysis

37. Small Animal Imaging (In-Vivo) Market Other Major And Innovative Companies

  • Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation

38. Global Small Animal Imaging (In-Vivo) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Small Animal Imaging (In-Vivo) Market

40. Small Animal Imaging (In-Vivo) Market High Potential Countries, Segments and Strategies

  • 40.1 Small Animal Imaging (In-Vivo) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Small Animal Imaging (In-Vivo) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Small Animal Imaging (In-Vivo) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer